296 related articles for article (PubMed ID: 26377263)
1. The phase value of putamen measured by susceptibility weighted images in Parkinson's disease and in other forms of Parkinsonism: a correlation study with F18 FP-CIT PET.
Kwon GH; Jang J; Choi HS; Hwang EJ; Jung SL; Ahn KJ; Kim BS; Yoo IeR; Kim SH; Haacke EM
Acta Radiol; 2016 Jul; 57(7):852-60. PubMed ID: 26377263
[TBL] [Abstract][Full Text] [Related]
2. The utility of susceptibility-weighted imaging for differentiating Parkinsonism-predominant multiple system atrophy from Parkinson's disease: correlation with 18F-flurodeoxyglucose positron-emission tomography.
Yoon RG; Kim SJ; Kim HS; Choi CG; Kim JS; Oh J; Chung SJ; Lee CS
Neurosci Lett; 2015 Jan; 584():296-301. PubMed ID: 25450142
[TBL] [Abstract][Full Text] [Related]
3. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
[TBL] [Abstract][Full Text] [Related]
4. Segmentation-based MR attenuation correction including bones also affects quantitation in brain studies: an initial result of 18F-FP-CIT PET/MR for patients with parkinsonism.
Choi H; Cheon GJ; Kim HJ; Choi SH; Lee JS; Kim YI; Kang KW; Chung JK; Kim EE; Lee DS
J Nucl Med; 2014 Oct; 55(10):1617-22. PubMed ID: 25134529
[TBL] [Abstract][Full Text] [Related]
5. Improved visual [(123)I]FP-CIT SPECT interpretation for evaluation of parkinsonism by visual rating of parametric distribution volume ratio images.
Meyer PT; Winz OH; Dafotakis M; Werner CJ; Krohn T; Schäfer WM
Q J Nucl Med Mol Imaging; 2011 Jun; 55(3):301-9. PubMed ID: 21532542
[TBL] [Abstract][Full Text] [Related]
6. Additional Role of Midbrain F-18 FP-CIT Uptake on PET in Evaluation of Essential Tremor and Parkinsonism.
Lee H; Sung YH; Hwang KH
Curr Med Imaging; 2023; 19(9):1041-1051. PubMed ID: 36734891
[TBL] [Abstract][Full Text] [Related]
7. Right putamen and age are the most discriminant features to diagnose Parkinson's disease by using
Cascianelli S; Tranfaglia C; Fravolini ML; Bianconi F; Minestrini M; Nuvoli S; Tambasco N; Dottorini ME; Palumbo B
Hell J Nucl Med; 2017; 20 Suppl():165. PubMed ID: 29324935
[TBL] [Abstract][Full Text] [Related]
8. Uneven age effects of [(18)F]FP-CIT binding in the striatum of Parkinson's disease.
Lee CS; Kim SJ; Oh SJ; Kim HO; Yun SC; Doudet D; Kim JS
Ann Nucl Med; 2014 Nov; 28(9):874-9. PubMed ID: 25008292
[TBL] [Abstract][Full Text] [Related]
9. [123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease.
Lorberboym M; Treves TA; Melamed E; Lampl Y; Hellmann M; Djaldetti R
Mov Disord; 2006 Apr; 21(4):510-4. PubMed ID: 16250023
[TBL] [Abstract][Full Text] [Related]
10. Initial diagnostic workup of parkinsonism: Dopamine transporter positron emission tomography versus susceptibility map-weighted imaging at 3T.
Sung YH; Lee J; Nam Y; Shin HG; Noh Y; Hwang KH; Lee H; Kim EY
Parkinsonism Relat Disord; 2019 May; 62():171-178. PubMed ID: 30580909
[TBL] [Abstract][Full Text] [Related]
11. An FP-CIT PET comparison of the difference in dopaminergic neuronal loss in subtypes of early Parkinson's disease.
Song IU; Chung YA; Oh JK; Chung SW
Acta Radiol; 2014 Apr; 55(3):366-71. PubMed ID: 23943629
[TBL] [Abstract][Full Text] [Related]
12. Quantitative evaluation of striatal I-123-FP-CIT uptake in essential tremor and parkinsonism.
Cuberas-Borrós G; Lorenzo-Bosquet C; Aguadé-Bruix S; Hernández-Vara J; Pifarré-Montaner P; Miquel F; Álvarez-Sabin J; Castell-Conesa J
Clin Nucl Med; 2011 Nov; 36(11):991-6. PubMed ID: 21975386
[TBL] [Abstract][Full Text] [Related]
13. Correlating Parkinson's disease motor symptoms with three-dimensional [(18)F]FP-CIT PET.
Chung M; Park YS; Kim JS; Kim YJ; Ma HI; Jang SJ; Huh R; Kim HS; Kim WC
Jpn J Radiol; 2015 Oct; 33(10):609-18. PubMed ID: 25952404
[TBL] [Abstract][Full Text] [Related]
14. 18F-FP-CIT PET imaging and SPM analysis of dopamine transporters in Parkinson's disease in various Hoehn & Yahr stages.
Wang J; Zuo CT; Jiang YP; Guan YH; Chen ZP; Xiang JD; Yang LQ; Ding ZT; Wu JJ; Su HL
J Neurol; 2007 Feb; 254(2):185-90. PubMed ID: 17334953
[TBL] [Abstract][Full Text] [Related]
15. Extrastriatal
Nicastro N; Fleury V; Broc N; Burkhard PR; Garibotto V
Parkinsonism Relat Disord; 2020 Sep; 78():38-43. PubMed ID: 32698058
[TBL] [Abstract][Full Text] [Related]
16. Comparison of perfusion 18F-FP-CIT PET and 99mTc-ECD SPECT in parkinsonian disorders.
Chun K; Kong E; Cho I
Medicine (Baltimore); 2021 Aug; 100(34):e27019. PubMed ID: 34449475
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of Computed Tomography-Guided Methods for Spatial Normalization of Dopamine Transporter Positron Emission Tomography Image.
Kim JS; Cho H; Choi JY; Lee SH; Ryu YH; Lyoo CH; Lee MS
PLoS One; 2015; 10(7):e0132585. PubMed ID: 26147749
[TBL] [Abstract][Full Text] [Related]
18. Validation of a standardized normalization template for statistical parametric mapping analysis of 123I-FP-CIT images.
Kas A; Payoux P; Habert MO; Malek Z; Cointepas Y; El Fakhri G; Chaumet-Riffaud P; Itti E; Remy P
J Nucl Med; 2007 Sep; 48(9):1459-67. PubMed ID: 17704252
[TBL] [Abstract][Full Text] [Related]
19. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism.
Lorberboym M; Djaldetti R; Melamed E; Sadeh M; Lampl Y
J Nucl Med; 2004 Oct; 45(10):1688-93. PubMed ID: 15471834
[TBL] [Abstract][Full Text] [Related]
20. Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson's disease.
Eshuis SA; Maguire RP; Leenders KL; Jonkman S; Jager PL
Eur J Nucl Med Mol Imaging; 2006 Feb; 33(2):200-9. PubMed ID: 16228235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
